“Improving BNT162b2 MRNA Vaccine Tolerability Without Efficacy Loss by Pidotimod Supplementation: Pidotimod in SARS-CoV-2 Vaccination”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 14, no. 1, Feb. 2022, p. e2022023, https://doi.org/10.4084/MJHID.2022.023.